跳至主要内容
临床试验/NCT01003470
NCT01003470Unknown2 期

Treating Apoplectic Sequela With Acupuncture: a Randomized Controlled Study

Tianjin University of Traditional Chinese Medicine1 个研究点 分布在 1 个国家目标入组 288 人开始时间: 2006年10月1日最近更新:
适应症

试验速览

阶段
2 期
发起方
入组人数
288
试验地点
1
主要终点
Score of neurological defect

研究概览

简要总结

The purpose of this study is to evaluate the therapeutic effect of acupuncture method of "Xing Nao Kai Qiao" for paralysis as an apoplectic sequela in a multicenter randomized and controlled clinical trial and to compare the efficacy between acupuncture and rehabilitation therapy. In addition, evaluating the trial in the view of medical economics.

详细描述

This study is a multi-center randomized controlled trial comparing three treatment groups.The trial is completed in the following three hospitals: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (TCM) of China, Tianjin Hospital of TCM of China, and Qingdao Haici Medical group of Shangdong province of China.

The total observation period within this study is 24 weeks for each patient. All patients should remain hemiplegia within 15~90 days after stroke. After randomization the patients will receive 4 sessions of 30 minutes' duration during a period of 4 weeks. The outcome measurement is completed both in the different times as follows: before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment.

288 patients were randomised into three groups: acupuncture group, rehabilitation group,and acupuncture plus rehabilitation group.The patients in the three groups are blinded as to which treatment method they received. The central randomization is used in this trial, which is performed by the Drug Clinical Research Center of Shanghai University of TCM of China. This trial is performed according to the principles of the Declaration of Helsinki (Version Edinburgh 2000). And the trial protocol has been approved by local institutional review board and ethics committee.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cerebral infarction diagnosed according to the diagnostic standard of western medicine
  • Apoplexy diagnosed according to the diagnostic standard of traditional Chinese medicine for apoplexy
  • Cerebral vascular accident occured in the internal carotid artery system which was verified by cerebral CT or MRI
  • The incidence of apoplexy less than twice and the time of onset 15~3 months
  • Age: 40-75 years, non-limited gender
  • NDS score of limb functional defect ≥10
  • The patient was alert and the vital signs are stable
  • Participant signed the informed consent form

排除标准

  • TIA or RIND
  • The nerve function defect induced by the cerebral tumor, trauma, parasitic diseases, heart disease and metabolic disorder or hemorrhagic cerebrovascular disease
  • Pregnant or breast-feeding women
  • Complicated with severe primary disease in heart, liver, kidney and hematology system or psychopath

结局指标

主要结局

Score of neurological defect

时间窗: before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment.

次要结局

  • Visualized anologue score(before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment.)
  • Spasm evaluation(before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment.)
  • Safety evaluation(before treatment, after the first treatment, 7, 14, 28days after treatment and follow up at 6 months after treatment.)

研究者

发起方
Tianjin University of Traditional Chinese Medicine
申办方类型
Other

研究点 (1)

Loading locations...

相似试验